Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of GERD in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece. The 'GERDQ-XS' Study

NCT01215305 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01215305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01215305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study on the Prevalence and Extraesophageal Symptoms of GERD in Patients With Upper GI Symptoms, Visiting the Outpatient Departments of Peripheral Hospitals in Greece. The 'GERDQ-XS' Study
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 31, 2010
Completion date
March 31, 2011
Enrollment
600 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease